Comparative Study
doi: 10.1007/978-3-642-81332-0_17.
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast
- PMID: 752852
- DOI: 10.1007/978-3-642-81332-0_17
Item in Clipboard
Comparative Study
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast
Recent Results Cancer Res.
1978.
Abstract
Following surgery and regional radiotherapy for operable carcinoma of the breast in premenopausal women, ovarian irradiation (2000 rad in five daily fractions) plus prednisone (7.5 mg per day) results in delayed recurrence and prolonged survival.
Similar articles
-
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.Breast Cancer Res Treat. 1983;3 Suppl:S45-8. doi: 10.1007/BF01855127. Breast Cancer Res Treat. 1983. PMID: 6367860 Clinical Trial.
-
Ovarian irradiation and prednisone therapy following surgery and radiotherapy for carcinoma of the breast.Can Med Assoc J. 1979 May 19;120(10):1221-9. Can Med Assoc J. 1979. PMID: 376074 Free PMC article. Clinical Trial.
-
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.Eur J Cancer (1965). 1980;Suppl 1:179-81. Eur J Cancer (1965). 1980. PMID: 7032930 Clinical Trial. No abstract available.
-
[Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].Orv Hetil. 2000 Jul 9;141(28):1551-5. Orv Hetil. 2000. PMID: 10957865 Review. Hungarian.
-
Breast cancer: improving outcome following adjuvant radiotherapy.Br J Radiol. 2004 Oct;77(922):811-20. doi: 10.1259/bjr/44576710. Br J Radiol. 2004. PMID: 15482992 Review.